… The aim of this study was to test whether genetic variants in PDE4D gene, a … genetic variants
in PDE4D gene as potential predictive factor of the response to a single dose of short-acting …

… variant in phosphodiesterase 4D (PDE4D)13 gene, an … the relationship between RGS5 gene
polymorphisms and … explore the association of RGS5 genetic variations and response to β2-…

… PDE families that display high affinity to cAMP, of which the PDE4A, 4B, 4C, and 4D mRNA
… ], alters ritodrine efficacy due to its association with physiological processes of the β2 agonist…

… the clinical response to repetitive administration of short-acting … The phosphodiesterase
(PDE) 4D subfamily is thought to be … no specific gene polymorphisms have been associated with …

… This is likely linked to the mucosal inflammatory response. … 32 allel G and 60.87 for allel A
RORA polymorphism of the … also activates and phosphorylates phosphodiesterase 4 (PDE4) …

… before and after administration of a short-acting β2-agonist. … ADRB2 polymorphisms on
treatment response to short-acting … examined the association of the ADRB2 polymorphisms and …

… treatment of systemic sclerosis (SSc)-associated ILD and other chronic fibrosing ILDs
with a … polymorphisms are correlated with ischaemic stroke [30] and response to short-acting …

… less than 0.7 after the administration of short acting bronchodilators, together with an impaired
… given polymorphism. Using these stricter standards for genetic association, the genes or …

… -1 Val762Ala polymorphism may be directly associated with … The predicting model to
short-acting bronchodilators was … the role of HNMT gene polymorphisms in the pathogenesis of …

… Genetic variants of PDE4D have been associated with the response to short-acting … siRNA
designed to silence all known cyclic nucleotide phosphodiesterase 4D (PDE4D) transcripts, or …